2026 Pediatric Rheumatology Symposium

March 18-21, 2026. Minneapolis, MN.

View by Number View by Title View Sessions

Friday, March 20, 2026

2:30PM-2:45PM: Abstract Number: 079

Still’s Disease Associated Lung Disease: Update From the European Registry

Plenary Abstract Session II

2:45PM-3:00PM: Abstract Number: 080

Expansion of Type I IFN-driven ISGhigh Monocytes and Identification of MAS-Associated CD8+ T cell Population During Macrophage Activation Syndrome

Plenary Abstract Session II

4:31PM-4:36PM: Abstract Number: 094

Identification of Distinct Disease Trajectory Patterns in Children with Chronic Nonbacterial Osteomyelitis (CNO) Using Unsupervised Machine Learning on Longitudinal Clinical Data from a Single Cohort of 267 Patients

Abstracts: Technology

4:31PM-4:36PM: Abstract Number: 133

Pathologic Lymphangiogenesis in Mouse Model and Patients with Pulmonary Arterial Hypertension

Abstracts: Pediatric Rheumatology Potpourri

4:31PM-4:36PM: Abstract Number: 126

Unmet Social Needs in Pediatric Rheumatic Disease: A Study of Disparities

Abstracts: Quality, Health Services, and Education Research

4:37PM-4:42PM: Abstract Number: 089

Anti-CD19 CAR-T Cell Therapy for the Treatment of Severe/Refractory Pediatric Autoimmune Diseases: A Single-Center Case Series

Abstracts: Technology

4:37PM-4:42PM: Abstract Number: 101

Identifying Intervention Targets to Reduce Emotional Distress and Improve Physical Activity in Juvenile Lupus and Dermatomyositis Patients: Longitudinal Analysis of Lupus Erythematosus and Dermatomyositis Stress and Cardiovascular Health Study Patient-Reported Resiliency Data

Abstracts: Pediatric Rheumatology Potpourri

4:37PM-4:42PM: Abstract Number: 118

Pain Experience and Treatment in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Systemic Lupus Erythematosus Registry

Abstracts: Quality, Health Services, and Education Research

4:43PM-4:48PM: Abstract Number: 132

AI-Assisted Body-Region Recognition for Localized Scleroderma: the 1st Step in Automated LoSCAT scoring

Abstracts: Quality, Health Services, and Education Research

4:43PM-4:48PM: Abstract Number: 114

Incidence of Inflammatory Arthritis Before and After Inflammatory Bowel Disease Diagnosis: A Population-Based Cohort Study

Abstracts: Pediatric Rheumatology Potpourri

4:43PM-4:48PM: Abstract Number: 115

KneeMS for Juvenile Idiopathic Arthritis

Abstracts: Technology

4:49PM-4:54PM: Abstract Number: 125

Educational Interventions to Increase Transition Preparedness in a Pediatric Rheumatology Clinic

Abstracts: Quality, Health Services, and Education Research

4:49PM-4:54PM: Abstract Number: 104

Identification of Joints with Active Arthritis from Clinical Notes with High Fidelity using a Large Language Model

Abstracts: Technology

4:49PM-4:54PM: Abstract Number: 117

Reliability of Pediatric-Specific Musculoskeletal Ultrasound Scanning Protocol for the Detection of Arthritis

Abstracts: Pediatric Rheumatology Potpourri

4:55PM-5:00PM: Abstract Number: 120

Bridging Evidence and Practice: New Institutional Pathway Increases Primary Intensification Rates for Children with High-Risk Kawasaki Disease

Abstracts: Quality, Health Services, and Education Research

1
2
3
…
5
Next Page»

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].